Artificial intelligence for optimizing benefits and minimizing risks of pharmacological therapies: challenges and opportunities
In recent years, there has been an exponential increase in the generation and accessibility of electronic healthcare data, often referred to as “real-world data”. The landscape of data sources has significantly expanded to encompass traditional databases and newer sources such as the social media, w...
Saved in:
Main Authors: | Salvatore Crisafulli, Francesco Ciccimarra, Chiara Bellitto, Massimo Carollo, Elena Carrara, Lisa Stagi, Roberto Triola, Annalisa Capuano, Cristiano Chiamulera, Ugo Moretti, Eugenio Santoro, Alberto Eugenio Tozzi, Giuseppe Recchia, Gianluca Trifirò |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-03-01
|
Series: | Frontiers in Drug Safety and Regulation |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fdsfr.2024.1356405/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Digital Therapeutics in Perspective: From Regulatory Challenges to Post-Marketing Surveillance
by: Salvatore Crisafulli, et al.
Published: (2022-06-01) -
A New Era of Pharmacovigilance: Future Challenges and Opportunities
by: Gianluca Trifirò, et al.
Published: (2022-02-01) -
Editorial: AI/ML in pharmacovigilance and pharmacoepidemiology
by: Wen Zou, et al.
Published: (2024-11-01) -
Development and design of the BELpREG registration system for the collection of real-world data on medication use in pregnancy and mother-infant outcomes
by: Laure Sillis, et al.
Published: (2023-05-01) -
Off-label and unlicensed utilization of drugs in a Brazilian pediatric hospital
by: Vanessa Pereira Gomes, et al.
Published: (2015-02-01)